Free Trial

New York State Teachers Retirement System Sells 7,665 Shares of McKesson Corporation (NYSE:MCK)

McKesson logo with Medical background

New York State Teachers Retirement System lessened its position in McKesson Corporation (NYSE:MCK - Free Report) by 6.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 103,329 shares of the company's stock after selling 7,665 shares during the quarter. New York State Teachers Retirement System owned 0.08% of McKesson worth $69,539,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in MCK. Brighton Jones LLC increased its stake in McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after acquiring an additional 798 shares during the last quarter. SVB Wealth LLC bought a new position in shares of McKesson during the fourth quarter valued at about $2,137,000. US Bancorp DE grew its stake in shares of McKesson by 0.8% during the fourth quarter. US Bancorp DE now owns 88,835 shares of the company's stock valued at $50,629,000 after buying an additional 684 shares during the last quarter. Hickory Point Bank & Trust bought a new position in shares of McKesson during the fourth quarter valued at about $342,000. Finally, Maia Wealth LLC bought a new position in shares of McKesson during the fourth quarter valued at about $241,000. Institutional investors own 85.07% of the company's stock.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 19,370 shares of the business's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $705.93, for a total value of $13,673,864.10. Following the sale, the chief executive officer now directly owns 51,243 shares of the company's stock, valued at approximately $36,173,970.99. The trade was a 27.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the business's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the completion of the transaction, the chief accounting officer now owns 1,972 shares of the company's stock, valued at $1,432,677.72. This represents a 21.59% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,117 shares of company stock valued at $23,526,451. 0.08% of the stock is currently owned by company insiders.

McKesson Price Performance

NYSE MCK opened at $725.99 on Monday. The business's 50-day moving average is $711.19 and its 200 day moving average is $653.10. The stock has a market capitalization of $90.83 billion, a PE ratio of 28.11, a PEG ratio of 1.45 and a beta of 0.49. McKesson Corporation has a 1 year low of $464.42 and a 1 year high of $736.36.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. The business had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. McKesson had a negative return on equity of 201.12% and a net margin of 0.92%. The business's revenue was up 18.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.18 EPS. As a group, equities research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.39%. The ex-dividend date of this dividend is Monday, June 2nd. McKesson's dividend payout ratio is currently 10.99%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MCK shares. Morgan Stanley raised their price objective on McKesson from $745.00 to $770.00 and gave the company an "overweight" rating in a research note on Wednesday, June 11th. Wells Fargo & Company set a $766.00 price objective on McKesson and gave the company an "equal weight" rating in a research note on Tuesday, June 3rd. Bank of America raised their price objective on McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Wall Street Zen raised McKesson from a "buy" rating to a "strong-buy" rating in a research note on Friday. Finally, Mizuho raised their price objective on McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research note on Thursday, April 3rd. Three analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $696.42.

Read Our Latest Analysis on MCK

McKesson Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Featured Stories

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in McKesson Right Now?

Before you consider McKesson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.

While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines